3-(2,2,2-Trifluoroethoxy)aniline hydrochloride, 95+%, 1g

(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, 95.0%, 10g

6-Boc-3,6-Diazabicyclo[3.2.0]heptane, 97.0%, 250mg

5-(2-chlorophenyl)-4H-1,2,4-triazol-3-amine, 95.0%, 250mg

1-(4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperidine, 98%, 1g

Tris(4-iodophenyl)amine>97.0%(GC)5g

Formic acid, ROTIPURAN® min. 85%, pa, 2.5 l, glass packaging

3,3'-Difluoro-[1,1'-biphenyl]-4,4'-dicarboxylic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-5 MS Ultra, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

N-(Pyrimidin-4-yl)acetamide, 98%, 250mg

4-Amino-3-phenyl-butyric acid HCl, 95.0%, 5g

(2S,4S)-Methyl 4-amino-1-benzoylpyrrolidine-2-carboxylate hydrochloride, 95%, 100mg

TERT-BUTYL 4-FLUORO-3-NITROBENZYLCARBAMATE, 95.0%, 10g